HK1144915A1 - 預防、治療和診斷利什曼病的利什曼原蟲固醇 -甲基轉移酶組合物 - Google Patents

預防、治療和診斷利什曼病的利什曼原蟲固醇 -甲基轉移酶組合物

Info

Publication number
HK1144915A1
HK1144915A1 HK10111591.8A HK10111591A HK1144915A1 HK 1144915 A1 HK1144915 A1 HK 1144915A1 HK 10111591 A HK10111591 A HK 10111591A HK 1144915 A1 HK1144915 A1 HK 1144915A1
Authority
HK
Hong Kong
Prior art keywords
leishmaniasis
methyltransferase
diagnosis
prevention
compositions
Prior art date
Application number
HK10111591.8A
Other languages
English (en)
Inventor
史蒂文‧里德
后藤康之
Original Assignee
傳染性疾病研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 傳染性疾病研究院 filed Critical 傳染性疾病研究院
Publication of HK1144915A1 publication Critical patent/HK1144915A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
HK10111591.8A 2007-07-13 2010-12-13 預防、治療和診斷利什曼病的利什曼原蟲固醇 -甲基轉移酶組合物 HK1144915A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94963707P 2007-07-13 2007-07-13
PCT/US2008/069843 WO2009012166A1 (en) 2007-07-13 2008-07-11 Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis

Publications (1)

Publication Number Publication Date
HK1144915A1 true HK1144915A1 (zh) 2011-03-18

Family

ID=39760688

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10111591.8A HK1144915A1 (zh) 2007-07-13 2010-12-13 預防、治療和診斷利什曼病的利什曼原蟲固醇 -甲基轉移酶組合物

Country Status (7)

Country Link
US (1) US8916168B2 (zh)
EP (1) EP2170372A1 (zh)
CN (1) CN101743016B (zh)
BR (1) BRPI0815565A2 (zh)
EA (1) EA017958B1 (zh)
HK (1) HK1144915A1 (zh)
WO (1) WO2009012166A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710155A2 (pt) 2006-04-10 2011-08-23 Infectious Disease Res Inst Inc compostos e métodos para diagnóstico e tratamento de leishmaniose
US8410258B2 (en) 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
BRPI0912768A2 (pt) * 2008-05-21 2016-05-17 Infectious Disease Res Inst vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose
BRPI0913972B1 (pt) 2008-07-03 2018-06-26 Infectious Disease Research Institute Polipeptídeo de fusão compreendendo antígenos de leishmania, polinucleotídeo, composição farmacêutica, bem como métodos para detecção de infecção e para identificação de leishmaniose e kit diagnóstico para detecção e identificação de leishmaniose
ES2352780B2 (es) * 2009-06-04 2011-09-15 Laboratorios Ovejero S.A. Lipopolisacárido de ochrobactrum intermedium contra la sepsis.
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
WO2012064659A1 (en) * 2010-11-08 2012-05-18 Infectious Disease Research Institute Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
ES2728865T3 (es) 2013-03-28 2019-10-29 Infectious Disease Res Inst Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9017698B2 (en) 2013-09-25 2015-04-28 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
EP3074003B1 (en) * 2013-11-26 2023-01-11 Zoetis Services LLC Compositions for induction of immune response
KR102411781B1 (ko) 2013-12-31 2022-06-22 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 단일 바이알 백신 제형
WO2017210364A1 (en) 2016-06-01 2017-12-07 Infectious Disease Research Institute Nanoalum particles containing a sizing agent
AU2020283768A1 (en) 2019-05-25 2021-12-23 Access To Advanced Health Institute Composition and method for spray drying an adjuvant vaccine emulsion
WO2022136952A1 (en) 2020-12-23 2022-06-30 Infectious Disease Research Institute Solanesol vaccine adjuvants and methods of preparing same
CN114250206B (zh) * 2021-12-25 2024-03-19 苏州瀚源新酶生物科技有限公司 甲基转移酶突变体、重组载体、重组工程菌及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Also Published As

Publication number Publication date
EA201070140A1 (ru) 2010-08-30
EP2170372A1 (en) 2010-04-07
BRPI0815565A2 (pt) 2015-02-18
US20090041798A1 (en) 2009-02-12
US8916168B2 (en) 2014-12-23
CN101743016A (zh) 2010-06-16
EA017958B1 (ru) 2013-04-30
CN101743016B (zh) 2015-05-13
WO2009012166A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
HK1144915A1 (zh) 預防、治療和診斷利什曼病的利什曼原蟲固醇 -甲基轉移酶組合物
HK1202558A1 (zh) 用於對流行性感冒進行治療以及診斷的組合物以及方法
EP2212440A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES
IL249165A0 (en) Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
EP2129683A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS
IL184312A0 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
EP2201370A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES
EP1969147A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA AND APPLYING TO THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS
IL212651A (en) Preparations for the treatment of acute lymphoblastic leukemia in children
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
EP2097012A4 (en) DEVICES AND METHOD FOR TREATING HEART FAILURE
ZA200806842B (en) Imidazole-based compounds,compositions comprising them and methods of their use
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
PL2086642T3 (pl) DNaza do leczenia męskiej subpłodności
GB0718446D0 (en) Compositions and methods for the treatment of infection
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
ZA201101278B (en) Compounds,compositions and methods for the treatment of b-amyloid diseases and synucleinopathies
EP2217238A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA
PL2209458T3 (pl) Kompozycje do traktowania skóry
GB0909297D0 (en) Composition for the treatment of skin conditions
ZA200808363B (en) Compounds and methods for diagnosis and treatment of leishmaniasis
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia